Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy of affective disorders.

B Alexander1, B Cook

  • 1College of Pharmacy, University of Iowa, Iowa City.

Primary Care
|September 1, 1990
PubMed
Summary

Accurate diagnosis of affective disorder subtypes guides effective treatment. Key therapies include TCAs, ECT, and MAOIs, with second-generation antidepressants reserved for specific cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Canadian yeast strains for novel new-make spirit applications.

FEMS yeast research·2026
Same author

O blood usage trends in the pediatric population 2015-2019: A multi-institutional analysis.

Transfusion·2025
Same author

Olfaction in the Anthropocene: NO<sub>3</sub> negatively affects floral scent and nocturnal pollination.

Science (New York, N.Y.)·2024
Same author

Epidemiology of healthcare-associated infection reported from a hospital-wide incidence study: considerations for infection prevention and control planning.

The Journal of hospital infection·2021
Same author

Impact of healthcare-associated infection on length of stay.

The Journal of hospital infection·2021
Same author

Personalized infection prevention and control: identifying patients at risk of healthcare-associated infection.

The Journal of hospital infection·2021

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Effective treatment of affective disorders hinges on precise diagnosis of depressive illness subtypes.
  • Current guidelines recommend specific first-line pharmacotherapies based on diagnosis.

Purpose of the Study:

  • To outline primary and secondary treatment strategies for various subtypes of affective disorders.
  • To delineate the role of different antidepressant classes and mood stabilizers.

Main Methods:

  • Review of established treatment algorithms for depressive and manic episodes.
  • Analysis of indications for various pharmacological agents including TCAs, MAOIs, ECT, lithium, carbamazepine, valproic acid, and verapamil.

Main Results:

  • TCAs are recommended for depressive episodes, ECT for psychotic features, and MAOIs for dysthymic/atypical depression.
  • Lithium is primary for mania and prophylaxis; carbamazepine, valproic acid, and verapamil are alternatives for refractory cases.
  • Second-generation antidepressants are typically second-line, used when their side-effect profiles are advantageous.

Conclusions:

  • Tailoring treatment to specific affective disorder subtypes improves patient outcomes.
  • A stepwise approach utilizing various pharmacological agents is crucial for managing complex and treatment-resistant cases.

Related Experiment Videos